Novartis AG DPO Ratio 2011-2026 | NVS

Annual DPO Ratio Novartis AG

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	102	119	114	114	109	95.9

All numbers in USD currency

Maximum	Minimum	Average
119	95.9	109

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Amgen AMGN	64.8	$ 349.77	0.57 %	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	31.7	$ 19.23	-1.38 %	$ 899 M	USA
Amarin Corporation plc AMRN	190	$ 14.6	0.76 %	$ 6.06 B	Irlanda
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	186	$ 2.63	0.77 %	$ 16.5 M	USA
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
Benitec Biopharma BNTC	-556	$ 11.19	1.91 %	$ 461 M	USA
Arbutus Biopharma Corporation ABUS	23	$ 4.42	4.25 %	$ 734 M	Canada
AIkido Pharma AIKI	32.8 K	-	1.93 %	$ 17.4 M	USA
Brickell Biotech BBI	105	-	-5.38 %	$ 6.06 M	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA